✦ LIBER ✦

Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma

✍ Scribed by Jeanette C. Yu; Alfred I. Neugut; Shuang Wang; Judith S. Jacobson; Lauren Ferrante; Vandana Khungar; Emerson Lim; Dawn L. Hershman; Robert S. Brown Jr; Abby B. Siegel

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 189 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24936

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreasing disparity in liver transplant

Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma : California, 1998-2005

✍ Anthony S. Robbins; Michael F. Daily; Christopher A. Aoki; Moon S. Chen Jr.; Chr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Persistent disparities in liver transpla

Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007

✍ Anthony S. Robbins; Derrick D. Cox; Lynt B. Johnson; Elizabeth M. Ward 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND: Prior studies have demonstrated that among patients with hepatocellular carcinoma (HCC), African Americans (AAs) and Asian/Pacific Islanders (APIs) are substantially less likely to undergo liver transplantation (LT) compared with whites. The authors examined whether disp

Racial disparities in the management of

Racial disparities in the management of hospitalized patients with cirrhosis and portal hypertension

✍ Robert P. Myers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

HCC, we agree with Sangiovanni and Iavarone that similar ultrasound surveillance intervals appear to be adequate for both patient groups, as recommended by international guidelines. Still, clinicians should be aware of the potentially higher oncogenic risk of genotype 1b in addition to other recogni

Use of surveillance for hepatocellular c

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States

✍ Jessica A. Davila; Robert O. Morgan; Peter A. Richardson; Xianglin L. Du; Kather 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is recommended but may not be performed. The extent and determinants of HCC surveillance are unknown. We conducted a population-based United States cohort study of patients over 65 years of age to examine use and determinants

Racial differences in the outcome of pat

Racial differences in the outcome of patients with colorectal carcinoma

✍ Rangaswamy Govindarajan; Rajesh V. Shah; Linda G. Erkman; Laura F. Hutchins 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Abstract ## BACKGROUND African‐American (AA) patients with colorectal carcinoma have a worse prognosis compared with Caucasians. To analyze the causes of this disparity in survival, a retrospective study of patients with colorectal carcinoma was undertaken. The impact of treatments received and

The prevalence of anti-hepatitis C virus

The prevalence of anti-hepatitis C virus among chinese patients with hepatocellular carcinoma

✍ Shou-Dong Lee; Fa-Yauh Lee; Jaw-Ching Wu; Shinn-Jang Hwang; Sun-Sang Wang; Kwang 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 2 views

To evaluate the role of hepatitis C virus (HCV) in Chinese patients with hepatocellular carcinoma (HCC), the antibodies to HCV (anti-HCV) were detected by enzyme immunoassay in 41 (12.6%) of the 326 patients with HCC. However, none of 35 patients with metastatic carcinoma of the liver had detectable